Regarding the brand new drug for Alzheimer’s illness collectively developed by Japanese and American pharmaceutical firms, the US FDA = Food and Drug Administration has introduced that it has been authorised as a therapeutic drug, saying that it has been confirmed to be efficient for sufferers.
Source
US FDA totally approves new drug “Lecanemab” for Alzheimer’s illness | NHK
